Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cooper Touts Growth Potential Of Proclear Line; Ocular Deal Nears Closure

This article was originally published in The Gray Sheet

Executive Summary

Cooper Companies expects sales of its Proclear multifocal contact lens line to roughly double to $25 mil. in fiscal 2005

You may also be interested in...



Cooper Companies Sheds Workers, Plants In Ocular Sciences Integration

With revenue flat compared with 2005 and the integration of Ocular Sciences ongoing, ophthalmic firm CooperVision plans to consolidate plants and reduce its sales force, according to its CEO

Cooper Companies Sheds Workers, Plants In Ocular Sciences Integration

With revenue flat compared with 2005 and the integration of Ocular Sciences ongoing, ophthalmic firm CooperVision plans to consolidate plants and reduce its sales force, according to its CEO

AMO’s Dual Vision: Contact Lens Presence, Global LASIK Growth

Advanced Medical Optics is considering increasing its stake in the contact lens market in 2005 by either expanding its licensing agreement with Cooper Companies or pursuing another acquisition

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021336

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel